Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01849744
Title Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Washington University School of Medicine, Division of Oncology Saint Louis Missouri 63110 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field